Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcus Biosciences (RCUS) Preferred Stock Liabilities (2017)

Historic Preferred Stock Liabilities for Arcus Biosciences (RCUS) over the last 1 years, with Q4 2017 value amounting to $226.2 million.

  • Arcus Biosciences' Preferred Stock Liabilities changed N/A to $226.2 million in Q4 2017 from the same period last year, while for Dec 2017 it was $226.2 million, marking a year-over-year change of. This contributed to the annual value of $226.2 million for FY2017, which is N/A changed from last year.
  • According to the latest figures from Q4 2017, Arcus Biosciences' Preferred Stock Liabilities is $226.2 million.
  • In the past 5 years, Arcus Biosciences' Preferred Stock Liabilities registered a high of $226.2 million during Q4 2017, and its lowest value of $226.2 million during Q4 2017.